The Technical Analyst
Bullfrog AI Holdings, [BFRG]
Exchange: NASDAQ Sector: Healthcare Industry: Medical - Healthcare Information Services
Bullfrog AI Holdings, Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-1.72% $2.85
America/New_York / 17 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 22.37 mill |
| EPS: | -0.890 |
| P/E: | -3.20 |
| Earnings Date: | May 22, 2024 |
| SharesOutstanding: | 7.85 mill |
| Avg Daily Volume: | 0.189 mill |
| RATING 2024-05-17 |
|---|
| B- |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | n/a | |||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.20 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -3.20 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.291 (-89.80%) $-2.56 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
$ 2.62 - 3.08 ( +/- 8.07%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-18 | Singh Vininder | Buy | 79 000 | Stock options (Right to buy) |
| 2024-01-22 | Singh Vininder | Sell | 25 000 | Common Stock |
| 2024-01-18 | Saglio Dane R | Buy | 34 500 | Stock options (Right to buy) |
| 2024-01-16 | Singh Vininder | Sell | 8 516 | Common Stock |
| 2024-01-17 | Singh Vininder | Sell | 4 848 | Common Stock |
| INSIDER POWER |
|---|
| 28.90 |
| Last 22 transactions |
| Buy: 278 500 | Sell: 125 000 |
Forecast:
16:00 - $2.89
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $2.89
Forecast 2: 16:00 - $2.89
Forecast 3: 16:00 - $2.89
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.85 (-1.72% ) |
| Volume | 0.0445 mill |
| Avg. Vol. | 0.189 mill |
| % of Avg. Vol | 23.62 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BFRG
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:32 | buy | $4.58 | N/A | Active |
|---|
BFRG
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
Latest Press Releases
2024-05-16 08:00:00 - Press Release
Bullfrog Ai And Lieber Institute For Brain Development Collaboration Identifies Novel Drug Targets For Neuropsychiatric Disorders
Gaithersburg, md., may 16, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug discovery company using artificial intelligence (ai) and machine learning to enable the successful discovery and development of pharmaceuticals and biologics, today announced significant advancements in its collaboration with the lieber institute for brain development (libd), including the identification of potential drug targets for multiple neuropsychiatric conditions.
2024-04-26 09:00:00 - Press Release
Bullfrog Ai And Greenpower Interviews To Air On The Redchip Small Stocks, Big Money(tm) Show On Bloomberg Tv
Orlando, fl / accesswire / april 26, 2024 / redchip companies will air interviews with bullfrog ai holdings, inc. (nasdaq:bfrg) and greenpower motor company inc. (nasdaq:gp) on the redchip small stocks, big money™ show, a sponsored program on bloomberg tv, this saturday, april 27, at 7 p.m. eastern time (et).
2024-03-08 08:00:00 - Press Release
Bullfrog Ai Announces Availability Of Fireside Chat Recording Featuring Ceos Of Bullfrog Ai And The Lieber Institute
Gaithersburg, md., march 08, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the availability of the recording for the recently held fireside chat. this enlightening session, hosted by redchip companies on march 5, 2024, featured bullfrog ai's ceo, vin singh, alongside daniel r. weinberger m.d., director and ceo of the lieber institute for brain development (libd).
2024-02-21 12:01:00 - Press Release
Bullfrog Ai Announces Underwriter's Decision To Exercise Over-allotment Option To Purchase 218,382 Shares Of The Company's Common Stock
Gaithersburg, md., feb. 21, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq:bfrg; bfrgw) (“bullfrog ai” or the “company”), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, announced february 21, 2024, the underwriter's decision to exercise their over-allotment option to purchase 218,382 shares of the company's common stock (the “option shares”), pursuant to the underwriting agreement, dated january 31, 2024, by and between bullfrog ai holdings, inc. and wallachbeth capital, llc as representative of the underwriters (the “underwriting agreement”).
2024-02-09 08:00:00 - Press Release
Bullfrog Ai To Discuss Findings From Its Collaboration With Lieber Institute For Brain Development In Fireside Chat Hosted By Redchip
Gaithersburg, md., feb. 09, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its ceo, vin singh, alongside distinguished guest, daniel r. weinberger, m.d., director and ceo of the lieber institute for brain development (libd), will participate in a fireside chat hosted by redchip companies on march 5, 2024 at 4:15 p.m. et.
Latest News
2024-05-16 08:00:00 - globenewswire.com
BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders
GAITHERSBURG, Md., May 16, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug discovery company using artificial intelligence (AI) and machine learning to enable the successful discovery and development of pharmaceuticals and biologics, today announced significant advancements in its collaboration with the Lieber Institute for Brain Development (LIBD), including the identification of potential drug targets for multiple neuropsychiatric conditions.
2024-04-26 09:00:00 - accesswire.com
BullFrog AI and GreenPower Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FL / ACCESSWIRE / April 26, 2024 / RedChip Companies will air interviews with BullFrog AI Holdings, Inc. (NASDAQ:BFRG) and GreenPower Motor Company Inc. (NASDAQ:GP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, April 27, at 7 p.m. Eastern Time (ET).
2024-04-02 14:29:03 - investorplace.com
The 3 Most Undervalued AI Penny Stocks to Buy in April 2024
If you are after the most undervalued AI penny stocks to buy in April, you have come to the right place. This article will explore several small-cap companies working on cutting-edge artificial intelligence technologies that could see explosive growth as AI continues its rapid advancement.
2024-03-08 08:00:00 - globenewswire.com
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
GAITHERSBURG, Md., March 08, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the availability of the recording for the recently held fireside chat. This enlightening session, hosted by RedChip Companies on March 5, 2024, featured BullFrog AI's CEO, Vin Singh, alongside Daniel R. Weinberger M.D., Director and CEO of the Lieber Institute for Brain Development (LIBD).
2024-03-06 22:54:54 - marketbeat.com
5 Under-the-Radar Artificial Intelligence (AI) Stocks
As the world continues its relentless march into the Artificial Intelligence (AI) era, the conversation around this transformative technology remains as vibrant as ever.
2024-03-04 09:31:23 - marketbeat.com
5 Under the Radar Artificial Intelligence (AI) Stocks
As the world continues its relentless march into the Artificial Intelligence (AI) era, the conversation around this transformative technology remains as vibrant as ever.
2024-02-23 06:50:00 - investorplace.com
7 AI Penny Stocks to Double Your Money: February 2024
Penny stocks representing companies integrating AI into products and services hold particularly interesting upside. Penny Shares are known to move upward rapidly and the emergence of AI continues to produce rapid gains.
2024-02-21 12:01:00 - globenewswire.com
BullFrog AI Announces Underwriter's Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company's Common Stock
GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced February 21, 2024, the Underwriter's decision to exercise their over-allotment option to purchase 218,382 shares of the Company's common stock (the “Option Shares”), pursuant to the Underwriting Agreement, dated January 31, 2024, by and between BullFrog AI Holdings, Inc. and WallachBeth Capital, LLC as representative of the Underwriters (the “Underwriting Agreement”).
2024-02-09 08:00:00 - globenewswire.com
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip
GAITHERSBURG, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its CEO, Vin Singh, alongside distinguished guest, Daniel R. Weinberger, M.D., Director and CEO of the Lieber Institute for Brain Development (LIBD), will participate in a fireside chat hosted by RedChip Companies on March 5, 2024 at 4:15 p.m. ET.
2024-02-05 10:15:00 - prnewswire.com
WallachBeth Capital Announces Closing Of Bullfrog AI $5.7 Million Public Offering
JERSEY CITY, N.J. , Feb. 5, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using (AI) and machine learning to enable the successful development of pharmaceuticals and biologics , has completed its previously announced underwritten public offering of an aggregate of 1,507,139 shares of common stock (or pre-funded warrants ("Pre-Funded Warrants") in lieu thereof) and accompanying warrants to purchase 1,507,139 shares of common stock at a public offering price of $3.782 per share (inclusive of the Pre-Funded Warrant exercise price) for gross proceeds of approximately $5,700,000, prior to deducting underwriting discounts and discount expenses.